Found 2030 results for "cancer"
The gap between what genetic science now knows about cancer risk and what most clinicians actually apply in practice may be one of the most consequential…
Early cancer interception rather than late-stage treatment represents medicine's most promising frontier, yet identifying who will develop lung cancer years…
Clear cell renal cell carcinoma occupies a unique niche in oncology precisely because its biology is defined by oxygen-sensing dysregulation — yet whether…
Lifelong restriction of valine — one of three branched-chain amino acids (BCAAs) — in C57BL/6J mice produced a 23% increase in median male lifespan, alongside…
For patients with glioblastoma — a brain cancer with a median survival under 18 months even with standard care — squeezing more efficacy from every available…
Geographic disparities in cancer treatment are often assumed to reflect patient preference or tumor biology — but when survival outcomes diverge along…
Heart failure during and after pregnancy has quietly become one of the most complex frontiers in women's cardiovascular medicine — and the population at risk…
For decades, the assumption that activating the retinoblastoma protein is unambiguously beneficial in hormone receptor-positive breast cancer has underpinned…
Lung disease kills millions annually, yet diagnosis still depends heavily on overburdened clinicians interpreting complex, heterogeneous data across imaging…
Colorectal cancer's stubborn resistance to immunotherapy has long been traced to its immunosuppressive tumor microenvironment — a cellular ecosystem dominated…
Pancreatic cancer remains one of oncology's most lethal diagnoses, with five-year survival rates still hovering near 12% for all stages combined. The absence…
For breast cancer patients undergoing chemotherapy, the tumor microenvironment — not just systemic drug exposure — may determine whether treatment succeeds or…
How a condition is named can be just as consequential as how it is treated — particularly in prostate pathology, where overtreatment of indolent tumors…
For the millions who survive dengue fever annually, recovery may not fully restore cellular integrity — a possibility that has profound implications for…
Understanding precisely which molecular actors translate DNA damage into permanent mutations is one of cancer biology's most consequential puzzles — because…
When cancer cells exploit two distinct molecular mechanisms simultaneously, conventional targeted therapies often fall short — and that gap is precisely where…
The central challenge of cancer immunotherapy has never been activation alone — it's breadth. Most tumors evade immune clearance not because T cells can't be…
When a child's cancer resists standard treatment, the options narrow rapidly — and for pediatric nephroblastoma (Wilms tumor) that has progressed through…
Personalized cancer treatment has long been constrained by a fundamental problem: clinicians cannot reliably predict which patients will benefit from a given…
For population-scale longevity research, the difference between a blood draw and a cheek swab is not merely procedural — it determines who gets studied, how…